Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.95 – $5.40
55% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.33B | $18.47B | $12.36B | $12.46B | $20.72B | $25.38B | $25.72B | $25.11B |
| Cost of revenue | $10.05B | $10.29B | $7.68B | $7.73B | $11.10B | $12.89B | $12.50B | $12.43B |
| Gross profit | $8.28B | $8.19B | $4.68B | $4.73B | $9.62B | $12.48B | $13.21B | $12.69B |
| Gross margin | 45.2% | 44.3% | 37.9% | 38.0% | 46.4% | 49.2% | 51.4% | 50.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $5.21B | $4.68B | $1.37B | $1.52B | $6.01B | $8.50B | $9.17B | $8.77B |
| EBITDA | $6.39B | $5.89B | $2.72B | $2.77B | $7.17B | $9.74B | $10.52B | $9.84B |
| Net income | $4.15B | $3.75B | $1.20B | $1.22B | $4.94B | $7.01B | $7.77B | $7.51B |
| Net margin | 22.7% | 20.3% | 9.7% | 9.8% | 23.8% | 27.6% | 30.2% | 29.9% |
| EPS (diluted) | 4.79 | 4.32 | 1.39 | 1.40 | 5.69 | 8.08 | 8.96 | 8.51 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $25.6B | $9.38 | $8.80–$10.76 | 1 |
| 2027 | $27.1B | $9.68 | $9.08–$11.10 | 1 |
| 2028 | $29.2B | $10.09 | $9.47–$11.58 | 1 |
Forward consensus · source: Financial Modeling Prep
BUMRUNGRAD HOSPITAL NVDR
No one on the platform currently holds BUGDF.
No tracked institution reports a position in BUGDF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-18 | $3.0000 | 2026-05-13 |
| 2026-03-18 | $6.0000 | 2026-05-13 |
| 2025-08-15 | $2.0000 | 2025-09-01 |
| 2025-03-20 | $3.0000 | 2025-05-15 |
| 2024-08-26 | $2.0000 | 2024-09-09 |
| 2024-03-13 | $3.1500 | 2024-05-15 |
| 2023-08-24 | $1.3500 | 2023-09-07 |
No one on the platform has traded BUGDF yet.
| +0.00% |
| $3.8B |
| — |
| NHNKYNihon Kohden Corporation | $8.76 | -0.82% | $2.8B | — |
| RHCGFRyman Healthcare Limited | $1.08 | +0.00% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.